Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models

NCT06372054 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2024-02-05
Last updated
2024-04-17

Condition(s) studied

Oxidative InjuryStress PhysiologicalDiscogenic PainCardiovascular Risk FactorSpace MaintenanceEpigenetic ChangesLONGEVITY 1NeuroplasticityNGS

Investigational drug(s) / intervention(s)

Biological sample collection

Biological sample collection: Collection of biological samples (blood, urine, saliva) and clinical data

Study summary

The goal of this observational study is to define a personalized risk model in the super healthy and homogeneous population of Italian Air Force high-performance pilots. This peculiar cohort conducts dynamic activities in an extreme environment, compared to a population of military people not involved in flight activity. The study integrates the analyses of biological samples (urine, blood, and saliva), clinical records, and occupational data collected at different time points and analyzed by omic-based approaches supported by Artificial Intelligence. Data resulting from the study will clarify many etiopathological mechanisms of diseases, allowing the creation of a model of analyses that can be extended to the civilian population and patient cohorts for the potentiation of precision and preventive medicine.

Eligibility

Sex
ALL
Min age
26 Years
Max age
38 Years
Healthy volunteers
No
Inclusion Criteria: * Being part of the Italian Air Force, as in active flight service or ground staff * Age between 26 and 38 years * Consent to collect biological samples and use the wearable device to monitor exposure parameters Exclusion Criteria: * Age \< 25 years and \> 39 years * no signature on informed consent

Primary outcome measure(s)

  • Assessment of flight-related exposure data and molecular modifications — Through study completion, an average of 3 year
    Collection of information on: i) lifestyle, ii) medical examination, iii) previous trauma, iv) cumulative professional exposure to flying, determination of panel of genes and circulating markers to assess prognostic and predictive factors

Trial sites (1)

FacilityCityRegionStatus
CeMATA - Joint Center for Aerospace Medicine and Advanced Therapy Milan Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06372054 on ClinicalTrials.gov ↗ ← All trials in Italy